BibleKC, KebebewE, BrierleyJ, et al.2021. American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer. Thyroid, 31: 337–386.
2.
JonklaasJ, BiancoAC, CappolaAR, et al.2021. Evidence-based use of levothyroxine/liothyronine combinations in treating hypothyroidism: a consensus document. Thyroid, 31: 156–182.
3.
van TrotsenburgP, StoupaA, LegerJ, et al.2021. Congenital hypothyroidism: a 2020–2021 consensus guidelines update-an ENDO-European reference network initiative endorsed by the European Society for pediatric endocrinology and the European Society for Endocrinology. Thyroid, 31: 387–419.
4.
GulecSA, AhujaS, AvramAM, et al.2021. A joint statement from the American Thyroid Association, the European Association of Nuclear Medicine, the European Thyroid Association, the Society of Nuclear Medicine and molecular imaging on current diagnostic and theranostic approaches in the management of thyroid cancer. Thyroid, 31: 1009–1019.
5.
SugitaniI, ItoY, TakeuchiD, et al.2021. Indications and strategy for active surveillance of adult low-risk papillary thyroid microcarcinoma: consensus statements from the Japan Association of Endocrine Surgery Task Force on Management for Papillary Thyroid Microcarcinoma. Thyroid, 31: 183–192.
6.
ChenM, ZhouW, XuW. 2021. Thyroid function analysis in 50 patients with COVID-19: a retrospective study. Thyroid, 31: 8–11.
7.
PlanckT, HedbergF, CalissendorffJ, NilssonA. 2021. Liothyronine use in hypothyroidism and its effects on cancer and mortality. Thyroid, 31: 732–739.
8.
PiekMW, PostmaEL, van LeeuwaardeR, et al.2021. The effect of radioactive iodine therapy on ovarian function and fertility in female thyroid cancer patients: a systematic review and meta-analysis. Thyroid, 31: 658–668.
